US 9975875
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 9975875 (Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity) held by Theravance Respiratory Company, LLC expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Respiratory Company, LLC
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K31/56, A61K45/06